Domov › Rakovina močového mechúra › Missouri › St. Louis
Klinické štúdie Rakovina močového mechúra v meste St. Louis, MO
22 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v meste St. Louis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Washington University School of Medicine, St Louis
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Prebieha náborFáza 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- a 1 ďalších
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Prebieha náborFáza 1
- Washington University School of Medicine in St. Louis, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- a 4 ďalších
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Washington University, School of Medicine, St Louis
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Prebieha náborFáza 2
- Cancer Care Center of O'Fallon, O'Fallon · 16 míľ odtiaľ
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 míľ odtiaľ
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- a 5 ďalších
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Prebieha náborFáza 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- a 5 ďalších
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Prebieha náborFáza 3
- Washington University School of Medicine, St Louis
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Prebieha náborFáza 1
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Prebieha náborFáza 1/2
- Washington University, St Louis
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Prebieha náborFáza 2
- Specialty Clinical Research of St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Prebieha náborObservačná štúdia
- Washington University School of Medicine, St Louis
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Prebieha náborFáza 2
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Prebieha náborFáza 3
- Renown Regional Medical Center, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Prebieha náborFáza 1
- Washington University in St. Louis, St Louis
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Prebieha náborFáza 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- a 4 ďalších
IDOV-Immune for Advanced Solid Tumors
Prebieha náborFáza 1
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Prebieha náborObservačná štúdia
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Prebieha náborObservačná štúdia
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, St Louis
Štúdie Rakovina močového mechúra v iných mestách
- New York City, NY35 štúdií
- Nashville, TN31 štúdií
- Houston, TX31 štúdií
- Dallas, TX27 štúdií
- Washington, DC26 štúdií
- Boston, MA26 štúdií
- Baltimore, MD24 štúdií
- Los Angeles, CA24 štúdií
- Seattle, WA21 štúdií
- Chicago, IL21 štúdií
- Philadelphia, PA21 štúdií
- Edison, NJ21 štúdií
Iné štúdie v St. Louis
- Nemalobunkový karcinóm pľúc73 štúdií
- Rakovina prsníka64 štúdií
- Metastatická rakovina54 štúdií
- Kolorektálny karcinóm50 štúdií
- Rakovina (všetky typy)46 štúdií
- Rakovina prostaty46 štúdií
- Rakovina pľúc39 štúdií
- Rakovina vaječníkov38 štúdií
- Rakovina pankreasu33 štúdií
- Rakovina endometria29 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku28 štúdií
- Srdcové zlyhanie26 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.